Denovo Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Denovo Biopharma's estimated annual revenue is currently $6.4M per year.
- Denovo Biopharma's estimated revenue per employee is $155,000
Employee Data
- Denovo Biopharma has 41 Employees.
- Denovo Biopharma grew their employee count by -7% last year.
Denovo Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO/Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Chief Development Officer / Chief Medical Officer | Reveal Email/Phone |
4 | Chief Technical Officer | Reveal Email/Phone |
5 | Chief Business Officer and Head US Finance | Reveal Email/Phone |
6 | Head Quality Assurance | Reveal Email/Phone |
7 | Sr VP CNS Development | Reveal Email/Phone |
8 | SVP, Global Head Drug Safety & PV | Reveal Email/Phone |
9 | VP, Clinical Development (Oncology) | Reveal Email/Phone |
10 | VP, Clinical Operations | Reveal Email/Phone |
Denovo Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Denovo Biopharma?
A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a private San Diego based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy or side effects. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in targeted patient population to achieve higher efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in most therapeutic areas, such as oncology and neurological diseases.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 41 | -18% | N/A |
#2 | $4.8M | 41 | 8% | N/A |
#3 | $7.5M | 41 | -13% | $269.2M |
#4 | $3.2M | 41 | -35% | $39.4M |
#5 | $8.9M | 41 | 3% | N/A |